日本を対象とした研究

Influence of the COVID-19 Pandemic on Overall Physician Visits and Telemedicine Use Among Patients With Type 1 or Type 2 Diabetes in Japan

(COVID-19が日本の1型糖尿病患者および2型糖尿病患者における受診や遠隔診療利用に及ぼした影響について)
Advance online publication
version.2: July 13, 2022
version.1: June 11, 2022

DOI: https://doi.org/10.2188/jea.JE20220032

Authors: Susumu Yagome, Takehiro Sugiyama, Kosuke Inoue, Ataru Igarashi, Ryotaro Bouchi, Mitsuru Ohsugi, Kohjiro Ueki, Atsushi Goto

ハイライト:

  • 1型糖尿病患者と2型糖尿病患者において、新型コロナウイルス感染症が拡大した2020年4月から5月にかけて、2019年の同月と比較して、受診数の低下と遠隔診療利用数のわずかな上昇がみられた。

  • 遠隔診療は受診継続に対して大きな貢献はしていなかった。

Highlights:

  • Suppression of overall physician visits during the spread of COVID-19 (April and May 2020) was observed compared to the same months in 2019 among patients with either type 1 or type 2 diabetes mellitus in Japan.

  • Telemedicine has not made a substantive contribution to continuous physician visits in Japan.

  • It was found that policies enacted to prevent the spread of COVID-19 were associated with suppression of physician visits and a slight increase in the utilization of telemedicine among patients with diabetes. This has important implications for policymakers.